Literature DB >> 16562081

Control of Tissue Reactions in Monkeys Vaccinated with Viable Coccidioides immitis by Prevaccination with Killed Coccidioides immitis.

J L Converse1, G A Deauville, E M Snyder, J G Ray, M E Seaquist.   

Abstract

Converse, J. L. (U.S. Army Biological Laboratories, Fort Detrick, Frederick, Md.), G. A. Deauville, E. M. Snyder, J. G. Ray, and M. E. Seaquist. Control of tissue reactions in monkeys vaccinated with viable Coccidioides immitis by prevaccination with killed Coccidioides immities. J. Bacteriol. 90:783-788. 1965.-Control of undesirable tissue reactions resulting from the subcutaneous injection of 150 viable arthrospores of Coccidioides immitis (strain D-76) was obtained by four injections of formalin-killed arthrospores 14, 12, 8, and 4 weeks (total dose, 36 mg) before injection of the viable arthrospores. Only 6 and 12% of these vaccinated animals exhibited ulceration and lymphadenopathy, respectively, as compared with 100 and 83% of the animals receiving only the viable vaccine. Agar-gel immunodiffusion precipitin titers of approximately 1:64 were evident 3 months after vaccination in animals receiving both vaccines, as compared with 1:128 in those injected with the viable vaccine alone. The above data indicated that somatic reactions to injection of a viable vaccine could be eliminated by preinjection of a killed vaccine. However, 6 months after vaccination, respiratory challenge (7,500 strain Cash arthrospores) indicated that this treatment also impaired the protective effect of the viable vaccine. All animals receiving both vaccines developed mild pulmonary coccidioidomycosis, whereas only 50% of the animals receiving only the viable vaccine were infected. In addition, the group receiving both vaccines demonstrated a more rapid and higher postchallenge precipitin titer. All vaccinated animals (those receiving the killed, the viable, or a combination of the two vaccines) survived for 4 months after challenge, as compared with 88% mortality (50% within 14 days) in the nonvaccinated controls.

Entities:  

Year:  1965        PMID: 16562081      PMCID: PMC315725          DOI: 10.1128/jb.90.3.783-788.1965

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  10 in total

1.  PRIMARY CUTANEOUS COCCIDIOIDOMYCOSIS. VISIBLE CLASSIC DEMONSTRATION OF DELAYED HYPERSENSITIVITY.

Authors:  D H GOODMAN; B SCHABARUM
Journal:  Ann Intern Med       Date:  1963-07       Impact factor: 25.391

2.  Coccidioidomycosis: a traveling fungus disease.

Authors:  E R HARRELL; W M HONEYCUTT
Journal:  Arch Dermatol       Date:  1963-02

3.  Immunization of mice against coccidioidomycosis.

Authors:  J L CONVERSE; M W CASTLEBERRY; A R BESEMER; E M SNYDER
Journal:  J Bacteriol       Date:  1962-07       Impact factor: 3.490

4.  Experimental subcutaneous coccidioidal infection in the mouse.

Authors:  D PAPPAGIANIS; C E SMITH; R J BERMAN; G S KOBAYASHI
Journal:  J Invest Dermatol       Date:  1959-05       Impact factor: 8.551

5.  Response of monkeys to respiratory challenge following subcutaneous inoculation with Coccidioides immitis.

Authors:  D PAPPAGIANIS; R L MILLER; C E SMITH; G S KOBAYASHI
Journal:  Am Rev Respir Dis       Date:  1960-08

6.  Nutritional requirements for the growth and arthrospore formation of Coccidioides immitis.

Authors:  E P GOLDSCHMIDT; G W TAYLOR
Journal:  J Bacteriol       Date:  1958-03       Impact factor: 3.490

7.  Primary cutaneous coccidioidomycosis; report of a case of a laboratory infection.

Authors:  J DOUCETTE; J R TRIMBLE
Journal:  AMA Arch Derm       Date:  1956-10

8.  AGAR-GEL PRECIPITIN TECHNIQUE IN ANTHRAX ANTIBODY DETERMINATIONS.

Authors:  J G RAY; P J KADULL
Journal:  Appl Microbiol       Date:  1964-07

9.  Antibiotic control of tissue reactions in dogs vaccinated with viable cells of Coccidioides immitis.

Authors:  M W Castleberry; J L Converse; P J Soto
Journal:  J Bacteriol       Date:  1964-05       Impact factor: 3.490

10.  Primary cutaneous coccidioidomycosis; the criteria for diagnosis and a report of a case.

Authors:  J W WILSON; C E SMITH; O A PLUNKETT
Journal:  Calif Med       Date:  1953-09
  10 in total
  3 in total

Review 1.  Experimentally induced immunity in the mycoses.

Authors:  Y C Kong; H B Levine
Journal:  Bacteriol Rev       Date:  1967-03

2.  Development of vaccines for coccidioidomycosis.

Authors:  H B Levine; D Pappagianis; J M Cobb
Journal:  Mycopathol Mycol Appl       Date:  1970

3.  Experimental irradiated arthrospore vaccine against coccidioidomycosis in mice.

Authors:  J D Pulliam; J L Converse; E M Snyder; J R Esterly; E P Lowe
Journal:  J Bacteriol       Date:  1967-11       Impact factor: 3.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.